Disease-Modifying Drugs for MS and Subsequent Health Service Use
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Disease-modifying drugs for multiple sclerosis and subsequent health service use
Mult. Scler. 2021 Dec 24;[EPub Ahead of Print], HS Ng, F Zhu, E Kingwell, Y Zhao, S Yao, O Ekuma, LW Svenson, C Evans, JD Fisk, RA Marrie, H TremlettFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.